Revised Surveillance Case Definition for HIV Infection - United States, 2014.


Following extensive consultation and peer review, CDC and the Council of State and Territorial Epidemiologists have revised and combined the surveillance case definitions for human immunodeficiency virus (HIV) infection into a single case definition for persons of all ages (i.e., adults and adolescents aged ≥13 years and children aged <13 years). The revisions were made to address multiple issues, the most important of which was the need to adapt to recent changes in diagnostic criteria. Laboratory criteria for defining a confirmed case now accommodate new multitest algorithms, including criteria for differentiating between HIV-1 and HIV-2 infection and for recognizing early HIV infection. A confirmed case can be classified in one of five HIV infection stages (0, 1, 2, 3, or unknown); early infection, recognized by a negative HIV test within 6 months of HIV diagnosis, is classified as stage 0, and acquired immunodeficiency syndrome (AIDS) is classified as stage 3. Criteria for stage 3 have been simplified by eliminating the need to differentiate between definitive and presumptive diagnoses of opportunistic illnesses. Clinical (nonlaboratory) criteria for defining a case for surveillance purposes have been made more practical by eliminating the requirement for information about laboratory tests. The surveillance case definition is intended primarily for monitoring the HIV infection burden and planning for prevention and care on a population level, not as a basis for clinical decisions for individual patients. CDC and the Council of State and Territorial Epidemiologists recommend that all states and territories conduct case surveillance of HIV infection using this revised surveillance case definition.

Download full-text


Available from: Bernard Branson, Apr 16, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In the United States, of the 1.1 million persons infected with human immunodeficiency virus (HIV) and the 2.7 million infected with hepatitis C virus (HCV), approximately 16% and 50%, respectively, are unaware of their infection. Highly effective treatments have turned both diseases into manageable conditions, and in the case of hepatitis C, a disease that can be cured. Early diagnosis is imperative so infected persons can take measures to stay healthy, get into care, benefit from therapy, and reduce the risk of transmission. In this report, we review current recommendations provided by the Centers for Disease Control and Prevention (CDC) and the United States Preventive Services Task Force on whom to screen for HIV and HCV infections, and recommendations from the CDC, the Association of Public Health Laboratories, and the Clinical and Laboratory Standards Institute on how to test for these infections.
    Clinical Infectious Diseases 05/2014; 59(6). DOI:10.1093/cid/ciu396 · 8.89 Impact Factor
  • Source

    Pediatrics in Review 07/2014; 35(7):268-86. DOI:10.1542/pir.35-7-268 · 0.82 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Key Clinical Points Care of the Asplenic Patient Asplenic patients are at risk for episodes of rapidly progressive septicemia that are fatal in up to 50% of cases. Asplenic patients should be informed that any illness with fever or severe symptoms without fever could indicate the onset of a life-threatening infection. Asplenic patients in whom fever develops should receive empirical antimicrobial therapy immediately. Vaccinations against pneumococci, Haemophilus influenzae type b, meningococci, and influenza virus are recommended for asplenic patients. Prophylactic antimicrobial therapy is generally recommended for asplenic children younger than 5 years of age and may be considered for older children and adults during the initial 1 to 2 years after splenectomy, with lifelong prophylaxis for persons who have had an episode of postsplenectomy sepsis.
    New England Journal of Medicine 07/2014; 371(4):349-356. DOI:10.1056/NEJMcp1314291 · 55.87 Impact Factor
Show more